Performance characteristics of the Cozart® RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration
Sherri L. Kacinko, Marilyn A. Huestis(Smithsonian Institution), Dene Baldwin, In‐Sook Kim(Frederick National Laboratory for Cancer Research), Allan J. Barnes(National Institutes of Health), Gail Cooper(Office of Chief Medical Examiner), Eric T. Moolchan(National Institute on Drug Abuse), Claire Reid, Chris Hand, Lisa Wilson
Cited by 43
Related Papers
Human Cannabinoid Pharmacokinetics
|Chemistry & Biodiversity|2007|1.1k
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
|Drug and Alcohol Dependence|2014|697
Neuropsychological Performance in Long-term Cannabis Users
|Archives of General Psychiatry|2001|656
Cannabis Effects on Driving Skills
|Clinical Chemistry|2012|613
Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid
|Journal of the American Society for Mass Spectrometry|2003|599